Abeona Therapeutics
(ABEO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,027 | -4,432 | -2,688 | -1,171 | -5,420 |
| Depreciation Amortization | 627 | 441 | 292 | 147 | 470 |
| Accounts receivable | 254 | 120 | 378 | 305 | -359 |
| Other Working Capital | 87 | -150 | 351 | 188 | 260 |
| Other Operating Activity | -213 | -79 | -337 | -264 | 719 |
| Operating Cash Flow | $-5,272 | $-4,100 | $-2,004 | $-795 | $-4,330 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,094 | 4,094 | -780 | -2,761 | -17,394 |
| PPE Investments | -419 | -317 | -34 | -5 | -70 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 4 |
| Investing Cash Flow | $3,675 | $3,777 | $-814 | $-2,766 | $-17,460 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 600 | 600 | N/A | N/A | 12,615 |
| Debt Repayment | -25 | N/A | N/A | N/A | -26 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -754 |
| Other Financing Activity | 33 | 31 | 18 | 15 | 17,505 |
| Financing Cash Flow | $608 | $631 | $18 | $15 | $29,340 |
| Beginning Cash Position | 8,415 | 8,415 | 8,415 | 8,415 | 860 |
| End Cash Position | 7,426 | 8,723 | 5,615 | 4,869 | 8,410 |
| Net Cash Flow | $-989 | $308 | $-2,800 | $-3,546 | $7,540 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,272 | -4,100 | -2,004 | -795 | -4,330 |
| Capital Expenditure | -419 | -317 | -34 | -5 | -72 |
| Free Cash Flow | -5,691 | -4,417 | -2,038 | -800 | -4,402 |